Ask AI

Decera Clinical Education's Independent Conference Highlights From the 2026 ASCO Annual Meeting

Review Capsule Summaries and a certified expert-authored ClinicalThought commentary highlighting key studies from the 2026 ASCO annual meeting.

For coverage of lymphoma and leukemia at ASCO and EHA 2026, click here.

Share

Program Content

Activities

RASolute 302
RASolute 302: Phase III Trial of Daraxonrasib vs Chemotherapy in Previously Treated Metastatic Pancreatic Adenocarcinoma
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 10, 2026

FIGHT-302
FIGHT-302: Phase III Trial of Pemigatinib as First-line Treatment for Unresectable Advanced or Metastatic Cholangiocarcinoma With FGFR2 Rearrangement
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 11, 2026

EMERALD-3
EMERALD-3: Phase III Trial of Tremelimumab + Durvalumab ± Lenvatinib Combined With TACE in Unresectable Embolization-Eligible HCC
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 11, 2026

HERIZON GEA 01 PDL1 Subgroup Analysis
HERIZON-GEA-01: PD-L1 Subgroup Analysis From Phase III Trial of Zanidatamab + Chemotherapy ± Tislelizumab for First-line HER2+ Locally Advanced or Metastatic GEA
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 16, 2026

HORIZON-CRC01
HORIZON-CRC01: Phase III Trial of Trastuzumab Rezetecan vs SoC in Chemorefractory, HER2+ Advanced CRC
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 16, 2026

Activities

IMforte Subtype and QTWiST Analyses
IMforte Phase III Trial: Transcriptomic and Q-TWiST Analyses of Lurbinectedin + Atezolizumab Maintenance Therapy in Extensive-Stage SCLC
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 22, 2026

LIBRETTO-432
LIBRETTO-432: Phase III Trial of Adjuvant Selpercatinib in Stage IB-IIIA RET Fusion–Positive NSCLC
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 15, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

Gastrointestinal Cancers
This activity is supported by an educational grant from Incyte Corporation.

Lung Cancer
This activity is supported by educational grants from Lilly and PharmaMar.

Breast Cancer
This activity is supported by educational grants from Lilly and Stemline Therapeutics, Inc. 

Incyte Corporation

Lilly

PharmaMar

Stemline Therapeutics, Inc.